Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.
Anastasios ManiakasAndrew SullivanMimi I HuNaifa L BusaidyMaria E CabanillasRamona DaduSteven G WaguespackSarah B FisherPaul H GrahamNeil D GrossElizabeth G GrubbsNancy D PerrierJennifer Rui WangBrandon GunnAdam S GardenRomy MegahedSriram NavuluriXu LiMichelle D WilliamsMark ZafereoPublished in: Head & neck (2023)
Use of PORT in MTC has decreased and its indications have become more selective, coinciding with the advent of effective targeted therapies. Overall, PORT was not associated with improved LRC or OS.